Institutional investors purchased a net $36.9 million shares of FOLD during the quarter ended December 2014 and now own 83.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 210.0 Thousand shares of Amicus Therapeutics Inc